Stojanovich L., Milovanovich B., de Luka SR et al. Cardiovascular autonomic dysfunction in systemic lupus, rheumatoid arthritis, primary Sjogren syndrome and other autoimmune diseases. Lupus2007; 16: 181—185.
2.
Hocevar A., Tomsic M., Praprotnik S. et al. Parasympathetic nervous system dysfunction in primary Sjogren's syndrome. Ann Rheum Dis2003; 62: 702—704.
3.
Haensch CA, Jorg J.Autonomic dysfunction in multiple sclerosis. J Neurol2006; 253: 3—9.
4.
Maule S., Quadri R., Mirante D. et al. Autonomic nervous dysfunction in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA): possible pathogenic role of autoantibodies to autonomic nervous structures. Clin Exp Immunol1997; 110: 423—427.
5.
Sternberg EMNeuroendocrine regulation of autoimmune/inflammatory disease. J Endocrinol2001; 169: 429—435.
6.
Tonelli L., Webster JI, Rapp KL et al. Neuroendocrine responses regulating susceptibility and resistance to autoimmune/inflammatory disease in inbred rat strains. Immunol Rev2001; 184: 203—211.
7.
Eskandari F., Webster JI, Sternberg EMNeural immune pathways and their connection to inflammatory diseases. Arthritis Res Ther2003; 5: 251—265.
8.
Shepherd AJ, Downing JE, Miyan JAWithout nerves, immunology remains incomplete - in vivo veritas. Immunology2005; 116: 145—163.
9.
Wrona D.Neural-immune interactions: an integrative view of the bidirectional relationship between the brain and immune systems. J Neuroimmunol2006; 172: 38—58.
10.
Berczi I.Neuroimmune biology — an introduction. In Berczi I, Gorezynski RM eds. New foundation of biology. Elsevier Science, 2001: 3—45.
11.
Schauenstein K., Rinner I., Felsner P. et al. The dialogue between the brain and immune system involves not only the HPA-axis. Z Rheumatol2000; 59: 49—53.
Tracey KJPhysiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest2007; 117: 289—296.
14.
Gallowitsch-Puerta M., Pavlov VANeuro-immune interactions via the cholinergic anti-inflammatory pathway. Life Sci2007; 80: 2325—2329.
15.
Borovikova LV, Ivanova S., Nardi D. et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature2000; 405: 458—462.
16.
Guarini S., Altavilla D., Cainazzo MM et al. Efferent vagal fibre stimulation blunts nuclear factor-kappaB activation and protects against hypovolemic hemorrhagic shock. Circulation2003; 107: 1189—1194.
17.
van Westerloo DJ, Giebelen IA, Florquin S. et al. The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology2006; 130: 1822—1830.
18.
van Westerloo DJ, Giebelen IA, Florquin S. et al. The cholinergic antiinflammatory pathway regulates the host response during septic peritonitis. J Infect Dis2005; 191: 2138—2148.
19.
Mabley JG, Pacher P., Southan GJ et al. Nicotine reduces the incidence of type I diabetes in mice. J Pharmacol Exp Ther2002; 300: 876—881.
20.
Patel GK, Rhodes JR, Evans B. et al. Successful treatment of pyoderma gangrenosum with topical 0.5% nicotine cream. J Dermatolog Treat2004; 15: 122—125.
21.
Burkhart CG , Burkhart CNThe use of nicotine in dermatology revisited . Int J Dermatol2001; 40: 731—732.
Bernik TR, Friedman SG, Ochani M. et al. Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med2002; 195: 781—788.
25.
Ulloa L.The vagus nerve and the nicotinic anti-inflammatory pathway. Nat Rev Drug Discov2005; 4: 673—684.
26.
Luyer MD, Greve JW, Hadfoune M. et al. Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve. J Exp Med2005; 202: 1023—1029.